8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d)

of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) October 4, 2018

 

 

NEOGEN CORPORATION

(Exact name of registrant as specified in its charter)

 

 

 

MICHIGAN   0-17988   38-2367843

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

620 Lesher Place Lansing, Michigan   48912
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code 517-372-9200

Not Applicable

(Former name or former address, if changed since last report.)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

 


Item 5.07

Submission of Matters to a Vote of Security Holders

On October 4, 2018, Neogen Corporation (the “Company”) held its 2018 Annual Meeting of Shareholders. At the meeting 48,080,133 of the 51,833,882 shares outstanding and entitled to vote were present and voted. The matters listed below were submitted to a vote of the shareholders though the solicitation of proxies. The proposals are described in detail in the Company’s Proxy Statement dated as of, and filed with Securities and Exchange Commission on, August 28, 2018. The voting results are as follows:

Proposal 1 – Election of Directors

 

Nominee

   For      Withheld  

James C. Borel

     42,531,954        454,606  

Ronald D. Green, Ph.D.

     39,509,603        3,476,957  

Darci L. Vetter

     42,553,883        432,677  

Proposal 2 – To Approve an Amendment to the Company’s Restated Articles of Incorporatiom, as Amended, to Increase the Number of Authorized Shares of Common Stock

The shareholders approved the amendment to the Company’s Restated Articles of Incorporation to increase the number of authorized shares of common stock.

 

For

 

Against

 

Abstain

 

Broker Non-Vote

46,722,766

  1,267,012   60,590   29,765

Proposal 3 – To Approve the Establishment of the Neogen Corporation 2018 Omnibus Incentive Plan

The shareholders approved the establishment of the Neogen Corporation 2018 Omnibus Incentive Plan.

 

For

 

Against

 

Abstain

 

Broker Non-Vote

39,730,261

  3,179,374   76,924   5,093,574

Proposal 4 – To Approve, by Non-Binding Vote, the Compensation of Executives

The shareholders approved, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in the proxy materials.

 

For

 

Against

 

Abstain

 

Broker Non-Vote

42,346,181

  502,855   137,523   5,093,574

Proposal 5 – Ratification of the Appointment of the Company’s Independent Registered Public Accounting Firm

The shareholders ratified the appointment of BDO USA LLP as the Company’s auditors for the fiscal year ending May 31, 2019.

 

For

 

Against

 

Abstain

 

Broker Non-Vote

47,775,169

  179,132   125,832   0


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

      NEOGEN CORPORATION
      (Registrant)
Date: October 5, 2018      
     

/s/ Steven J. Quinlan

      Steven J. Quinlan
      Vice President & CFO